Error: Contact form not found.
Bhringraj oil, extracted from the Eclipta alba plant, has long been valued in Ayurvedic haircare for its ability to support hair density, scalp nourishment, and natural pigmentation. The oil carries a rich nutrient profile suited for premium hair serums, scalp treatments, and traditional formulations developed by cosmetic, pharmaceutical, and wellness brands.
Sivaroma operates as a trusted Bhringraj Oil Manufacturer in India, combining classical extraction wisdom with modern processing controls to deliver consistent batches. Buyers source from us for purity, repeatable specifications, and bulk readiness aligned with formulation timelines.
Our position among leading Bhringraj Oil Manufacturers reflects 25+ years of natural oils expertise, certified facilities, and steady production output. Globally, we are recognized among capable Bhringraj Oil Exporters serving cosmetic, pharmaceutical, and Ayurvedic clients across regulated international markets.
Reliability comes down to consistent sourcing, transparent testing, and infrastructure that scales with order volume. Buyers should look for international certifications such as USFDA, WHO GMP, ISO 9001:2015, HACCP, FSSAI, Halal, and Kosher, alongside lot-level certificates of analysis attached to every shipment. Sivaroma operates a 1200 square meter facility with 15 tons daily capacity, supporting cosmetic and Ayurvedic brands worldwide. Buyers gain predictable lead times, clear documentation, and oil specifications that hold steady from sample to production order, reducing reformulation risks during scale-up.
Our supply model is built for both small private label brands and large pharmaceutical buyers who need scheduled deliveries. As an experienced Bhringraj Oil Supplier in India, we maintain dedicated warehousing across five storage units, supporting variable order quantities and consolidated international shipments. Documentation typically includes a certificate of analysis, MSDS, allergen statement, and origin proof, which simplify customs clearance in Europe, North America, and Gulf markets. Clients also receive packaging options ranging from HDPE drums to plastic bottles, matched to their downstream formulation and storage needs.
A certified exporter reduces customs friction and protects formulation integrity during transit. Working with Sivaroma as a Bhringraj Oil Exporter in India means each consignment carries verified test parameters, GMP-aligned packaging, and origin documentation accepted across regulated markets. Our facility holds USFDA, ISO 9001:2015, HACCP, and FSSAI compliance, while Halal and Kosher status supports buyers in Gulf and Jewish-market segments. Shipments move through standardized HDPE drums and GI drums, helping pharmaceutical and cosmetic clients maintain product integrity from port of dispatch through final formulation runs.
Experience shows up in three areas: raw material control, batch repeatability, and post-sale technical support. Long-standing suppliers typically operate validated quality systems, traceable supply chains, and laboratories capable of GC analysis, heavy metal screening, and microbial testing. Sivaroma carries 25+ years of operating history, serves 1500+ clients, and lists trusted brands such as Cipla, Bajaj, Emami, Patanjali, Himalaya, and Dabur among its long-term partners. That track record signals stable inputs, formulation compatibility data, and responsive handling when buyers request customization or scale-up across regions.
Quality assurance starts at sourcing, not at the finishing line. At Sivaroma, raw Eclipta alba is procured from vetted Indian farms, processed under WHO GMP conditions, and tested for purity, density, and contamination markers before packing. Each export consignment carries a lot-level certificate of analysis with parameters mapped to importing country regulations. This documentation supports faster regulatory clearance in the USA, Canada, Europe, and Gulf nations, while reducing the risk of port rejection and protecting buyer formulation timelines across cosmetic and pharmaceutical segments.
